TERT promoter mutations and TERT mRNA but not FGFR3 mutations are urinary biomarkers in Han Chinese patients with urothelial bladder cancer.
about
Cancer-Specific Telomerase Reverse Transcriptase (TERT) Promoter Mutations: Biological and Clinical ImplicationsTranscription Regulation of the Human Telomerase Reverse Transcriptase (hTERT) GeneThe association between the TERT rs2736100 AC genotype and reduced risk of upper tract urothelial carcinomas in a Han Chinese populationThe TERT promoter mutation incidence is modified by germline TERT rs2736098 and rs2736100 polymorphisms in hepatocellular carcinoma.The genetic difference between Western and Chinese urothelial cell carcinomas: infrequent FGFR3 mutation in Han Chinese patients.Detection of multiple mutations in urinary exfoliated cells from male bladder cancer patients at diagnosis and during follow-upUnderstanding TERT Promoter Mutations: A Common Path to Immortality.TERT promoter mutation status in sarcomatoid urothelial carcinomas of the upper urinary tract.miR-186 downregulates protein phosphatase PPM1B in bladder cancer and mediates G1-S phase transition.Toward Personalised Liquid Biopsies for Urothelial Carcinoma: Characterisation of ddPCR and Urinary cfDNA for the Detection of the TERT 228 G>A/T Mutation.Paris Polyphylla-Derived Saponins Inhibit Growth of Bladder Cancer Cells by Inducing Mutant P53 Degradation While Up-Regulating CDKN1A Expression.TERT Promoter Hypermethylation in Gastrointestinal Cancer: A Potential Stool Biomarker.Telomere Maintenance Mechanisms in Cancer.
P2860
Q26738705-70375433-35BA-4EF1-B447-B8D9C965DA6AQ26739925-10A1EF09-24EA-41F2-A0B5-C60B0A15DDB2Q28392404-0AA7083D-A406-49F2-856A-95F1F5733495Q33618591-FC448A25-E37A-454E-AE63-06894B10CE48Q37295512-DDED7420-CCB2-45C6-BA8F-958D8AA258D5Q37687183-71C3AEFC-00F2-43D6-9E98-C252DB26EBA6Q38760235-666C3959-5F34-4607-8024-87E9C581EC0AQ38774845-30BACADD-4CFE-46FE-B1E1-997E641D0ABFQ38825749-CBC4A72D-8205-4051-A13C-F375B20E240BQ50072573-5B56E8EB-638B-4E01-906E-97FF82A64973Q52716922-20ED139F-6423-4059-B6A2-95DA55751363Q54522397-93055CAB-232E-45BE-9E2B-A0CD5C5CC32AQ55443450-398F2247-F0FC-46E1-8AC1-55505FF7D8A8
P2860
TERT promoter mutations and TERT mRNA but not FGFR3 mutations are urinary biomarkers in Han Chinese patients with urothelial bladder cancer.
description
2015 nî lūn-bûn
@nan
2015 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
TERT promoter mutations and TE ...... ith urothelial bladder cancer.
@ast
TERT promoter mutations and TE ...... ith urothelial bladder cancer.
@en
type
label
TERT promoter mutations and TE ...... ith urothelial bladder cancer.
@ast
TERT promoter mutations and TE ...... ith urothelial bladder cancer.
@en
prefLabel
TERT promoter mutations and TE ...... ith urothelial bladder cancer.
@ast
TERT promoter mutations and TE ...... ith urothelial bladder cancer.
@en
P2093
P2860
P1433
P1476
TERT promoter mutations and TE ...... ith urothelial bladder cancer.
@en
P2093
Chang Wang
Hongbo Ren
Keqiang Yan
Sanyuan Hu
P2860
P304
P356
10.1634/THEONCOLOGIST.2014-0391
P577
2015-02-05T00:00:00Z